RETATRUTIDE: A THOROUGH EXAMINATION

The increasingly popular class of GLP-1 receptor agonist and GIP co-agonist medications, such as tirzepatide, semaglutide, and the recently introduced retatrutide, provide significant improvements in the control. While all three work by modulating glucose concentrations, they distinguish in their